Deletion of CD38 Suppresses Glial Activation and Neuroinflammation in a Mouse Model of Demyelination
Open Access
- 6 June 2019
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 13, 258
Abstract
CD38 is an enzyme that catalyzes the synthesis of cyclic adenosine diphosphate-ribose from nicotinamide adenine dinucleotide (NAD+). We recently reported that this molecule regulates the maturation and differentiation of glial cells such as astrocytes and oligodendrocytes (OLs) in the developing brain. To analyze its role in the demyelinating situation, we employed cuprizone (CPZ)-induced demyelination model in mice, which is characterized by oligodendrocyte-specific apoptosis, followed by the strong glial activation, demyelination, and repopulation of OLs. By using this model, we found that CD38 was upregulated in both astrocytes and microglia after CPZ administration. Experiments using wild-type and CD38 knockout (KO) mice, together with those using cultured glial cells, revealed that CD38 deficiency did not affect the initial decrease of the number of OLs, while it attenuated CPZ-induced demyelination, and neurodegeneration. Importantly, the clearance of the degraded myelin and oligodendrocyte repopulation were also reduced in CD38 KO mice. Further experiments revealed that these observations were associated with reduced levels of glial activation and inflammatory responses including phagocytosis, most likely through the enhanced level of NAD+ in CD38-deleted condition. Our results suggest that CD38 and NAD+ in the glial cells play a critical role in the demyelination and subsequent oligodendrocyte remodeling through the modulation of glial activity and neuroinflammation.Keywords
This publication has 48 references indexed in Scilit:
- Sildenafil (Viagra) Protective Effects on Neuroinflammation: The Role of iNOS/NO System in an Inflammatory Demyelination ModelMediators of Inflammation, 2013
- Neurobiological effects of sphingosine 1‐phosphate receptor modulation in the cuprizone modelThe FASEB Journal, 2011
- FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P 1 ) modulationProceedings of the National Academy of Sciences, 2010
- Sphingosine 1‐phosphate receptor 1 and 3 are upregulated in multiple sclerosis lesionsGlia, 2010
- CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelinationProceedings of the National Academy of Sciences, 2010
- CD38 Facilitates Recovery from Traumatic Brain InjuryJournal of Neurotrauma, 2009
- Multiple sclerosisThe Lancet, 2008
- Expression of an acyl‐CoA synthetase, lipidosin, in astrocytes of the murine brain and its up‐regulation during remyelination following cuprizone‐induced demyelinationJournal of Neuroscience Research, 2007
- Microglial Recruitment, Activation, and Proliferation in Response to Primary DemyelinationThe American Journal of Pathology, 2007
- Observations on oligodendrocyte degeneration, the resolution of status spongiosus and remyelination in cuprizone intoxication in miceJournal of Neurocytology, 1972